nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acetylation-dependent deubiquitinase USP26 stabilizes BAG3 to promote breast cancer progression
|
Liu, Jiazhou |
|
|
597 |
C |
p. |
artikel |
2 |
Activated STING-containing R-EVs from iPSC-derived MSCs promote antitumor immunity
|
Qian, Linxia |
|
|
597 |
C |
p. |
artikel |
3 |
Biological activity of a stable 6-aryl-2-benzoyl-pyridine colchicine-binding site inhibitor, 60c, in metastatic, triple-negative breast cancer
|
Oluwalana, Damilola |
|
|
597 |
C |
p. |
artikel |
4 |
CDK4/6 inhibition augments anti-tumor efficacy of XPO1 inhibitor selinexor in natural killer/T-cell lymphoma
|
Wang, Yali |
|
|
597 |
C |
p. |
artikel |
5 |
CD39 transforming cancer therapy by modulating tumor microenvironment
|
Xu, Suling |
|
|
597 |
C |
p. |
artikel |
6 |
Cholesterol-ferroptosis nexus: Unveiling novel cancer therapeutic avenues
|
Lee, Jaewang |
|
|
597 |
C |
p. |
artikel |
7 |
Corrigendum to “Early functional mismatch between breast cancer cells and their tumour microenvironment suppresses long term growth” [Cancer Lett. 544 (2022), 215800]
|
Perdrix Rosell, Anna |
|
|
597 |
C |
p. |
artikel |
8 |
Corrigendum to “scRNA-Seq and imaging mass cytometry analyses unveil iNKT cells-mediated anti-tumor immunity in pancreatic cancer liver metastasis” [Cancer Lett. (2023 May 1) 561 216149]
|
Yi, Qijun |
|
|
597 |
C |
p. |
artikel |
9 |
Deciphering the TCF19/miR-199a-5p/SP1/LOXL2 pathway: Implications for breast cancer metastasis and epithelial-mesenchymal transition
|
Li, Shu-yu |
|
|
597 |
C |
p. |
artikel |
10 |
Development and evaluation of a risk prediction tool for risk-adapted screening of colorectal cancer in China
|
Hang, Dong |
|
|
597 |
C |
p. |
artikel |
11 |
Development of NR0B2 as a therapeutic target for the re-education of tumor associated myeloid cells
|
Vidana Gamage, Hashni Epa |
|
|
597 |
C |
p. |
artikel |
12 |
Dual inhibition of the TrkA and JAK2 pathways using entrectinib and pacritinib suppresses the growth and metastasis of HER2-positive and triple-negative breast cancers
|
Regua, Angelina T. |
|
|
597 |
C |
p. |
artikel |
13 |
Editorial Board
|
|
|
|
597 |
C |
p. |
artikel |
14 |
First report: PLATFORM study for precision treatment of rare tumors in China
|
Zhou, Jiawei |
|
|
597 |
C |
p. |
artikel |
15 |
FOXK2 amplification promotes breast cancer development and chemoresistance
|
Yu, Yang |
|
|
597 |
C |
p. |
artikel |
16 |
Hepatocellular carcinoma and lipid metabolism: Novel targets and therapeutic strategies
|
Cao, Lu-Qi |
|
|
597 |
C |
p. |
artikel |
17 |
HIF-2α inhibition disrupts leukemia stem cell metabolism and impairs vascular microenvironment to enhance chronic myeloid leukemia treatment
|
Wang, Jian |
|
|
597 |
C |
p. |
artikel |
18 |
Interplay among extracellular vesicles, cancer stemness and immune regulation in driving hepatocellular carcinoma progression
|
Tsui, Yu-Man |
|
|
597 |
C |
p. |
artikel |
19 |
Lysosomal exocytosis: From cell protection to protumoral functions
|
Trojani, Marie-Charlotte |
|
|
597 |
C |
p. |
artikel |
20 |
Metabolic reprogramming in tumor immune microenvironment: Impact on immune cell function and therapeutic implications
|
Liu, Yuqiang |
|
|
597 |
C |
p. |
artikel |
21 |
Methylation synthetic lethality: Exploiting selective drug targets for cancer therapy
|
Ye, Bing-Jie |
|
|
597 |
C |
p. |
artikel |
22 |
METTL3 regulates M6A methylation-modified EBV-pri-miR-BART3-3p to promote NK/T cell lymphoma growth
|
Wu, Shaojie |
|
|
597 |
C |
p. |
artikel |
23 |
NR0B2 re-educates myeloid immune cells to reduce regulatory T cell expansion and progression of breast and other solid tumors
|
Vidana Gamage, Hashni Epa |
|
|
597 |
C |
p. |
artikel |
24 |
NSUN4 mediated RNA 5-methylcytosine promotes the malignant progression of glioma through improving the CDC42 mRNA stabilization
|
Zhao, Zhen |
|
|
597 |
C |
p. |
artikel |
25 |
Overactivation of XBP1 in plasma cells implies worse survival through innate immunity in esophageal squamous cell carcinoma
|
Yin, Yin |
|
|
597 |
C |
p. |
artikel |
26 |
Patient derived cancer organoids model the response to HER2-CD3 bispecific antibody (BsAbHER2) generated from hydroxyapatite gene delivery system
|
Liu, Yuhong |
|
|
597 |
C |
p. |
artikel |
27 |
PDP1 promotes KRAS mutant colorectal cancer progression by serving as a scaffold for BRAF and MEK1
|
Yuan, Ming |
|
|
597 |
C |
p. |
artikel |
28 |
Peripheral CD8+PD-1+ T cells as novel biomarker for neoadjuvant chemoimmunotherapy in humanized mice of non-small cell lung cancer
|
Guo, Wenwen |
|
|
597 |
C |
p. |
artikel |
29 |
PI3K inhibitor idelalisib enhances the anti-tumor effects of CDK4/6 inhibitor palbociclib via PLK1 in B-cell lymphoma
|
Hu, Dingyao |
|
|
597 |
C |
p. |
artikel |
30 |
PROX1 drives neuroendocrine plasticity and liver metastases in prostate cancer
|
Liu, Chunyu |
|
|
597 |
C |
p. |
artikel |
31 |
Sideroflexin-1 promotes progression and sensitivity to lapatinib in triple-negative breast cancer by inhibiting TOLLIP-mediated autophagic degradation of CIP2A
|
Andriani, Lisa |
|
|
597 |
C |
p. |
artikel |
32 |
SLC4A4 is a novel driver of enzalutamide resistance in prostate cancer
|
Chen, Hao-Jie |
|
|
597 |
C |
p. |
artikel |
33 |
Targeting S6K/NFκB/SQSTM1/Polθ signaling to suppress radiation resistance in prostate cancer
|
Clark, Alison |
|
|
597 |
C |
p. |
artikel |
34 |
The mechanism of extracellular CypB promotes glioblastoma adaptation to glutamine deprivation microenvironment
|
Yin, Hang |
|
|
597 |
C |
p. |
artikel |
35 |
The safety and efficacy outcomes of Minnelide given alone or in combination with paclitaxel in advanced gastric cancer: A phase I trial
|
Lim, Sung Hee |
|
|
597 |
C |
p. |
artikel |
36 |
The underlying mechanism of chimeric antigen receptor (CAR)-T cell therapy triggering secondary T-cell cancers: Mystery of the Sphinx?
|
Zhou, Zhaokai |
|
|
597 |
C |
p. |
artikel |
37 |
Unlocking the potential of Berberine: Advancing cancer therapy through chemosensitization and combination treatments
|
Sajeev, Anjana |
|
|
597 |
C |
p. |
artikel |
38 |
Unveiling major histocompatibility complex-mediated pan-cancer immune features by integrated single-cell and bulk RNA sequencing
|
Feng, Hao-Ran |
|
|
597 |
C |
p. |
artikel |
39 |
YBX1 promotes homologous recombination and resistance to platinum-induced stress in ovarian cancer by recognizing m5C modification
|
Meng, Huangyang |
|
|
597 |
C |
p. |
artikel |
40 |
YTHDF1 promotes the osteolytic bone metastasis of breast cancer via inducing EZH2 and CDH11 translation
|
Wang, Shuoer |
|
|
597 |
C |
p. |
artikel |